Kendra K Radtke

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Clinical Decision Support

Machine Learning

Mycobacterium Tuberculosis

Top Venues

Clinical pharmacology and therapeutics

Antimicrobial agents and chemotherapy

The European respiratory journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

This page only lists publications with an associated author ORCID identifier.

Publications

Anu Patel, Sarah B Doernberg, Travis Zack, Atul Janardhan Butte, Kendra K Radtke
Predictive Modeling of Drug-Related Adverse Events with Real-World Data: A Case Study of Linezolid Hematologic Outcomes. Clinical pharmacology and therapeutics 115 (4) (2024)
Anu Patel, Sarah B Doernberg, Travis Zack, Atul Janardhan Butte, Kendra K Radtke
Predictive Modeling of Drug-Related Adverse Events with Real-World Data: A Case Study of Linezolid Hematologic Outcomes. Clinical pharmacology and therapeutics 115 (4) (2024)
Anu Patel, Sarah B Doernberg, Travis Zack, Atul Janardhan Butte, Kendra K Radtke
Predictive Modeling of Drug-Related Adverse Events with Real-World Data: A Case Study of Linezolid Hematologic Outcomes. Clinical pharmacology and therapeutics 115 (4) (2024)
Anu Patel, Sarah B Doernberg, Travis Zack, Atul Janardhan Butte, Kendra K Radtke
Predictive Modeling of Drug-Related Adverse Events with Real-World Data: A Case Study of Linezolid Hematologic Outcomes. Clinical pharmacology and therapeutics (2024)
Ali Mohamed Ali, Kendra K Radtke, Anneke C Hesseling, Jana Winckler, H Simon Schaaf, Heather R Draper, Belen P Solans, Louvina E van der Laan, Jennifer Hughes, Barend Fourie, James Nielsen, Anthony J Garcia-Prats, Radojka M Savic
QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies. Antimicrobial agents and chemotherapy (2023)
Kendra K Radtke, Anneke C Hesseling, J L Winckler, Heather R Draper, Belen P Solans, Stephanie Thee, Lubbe Wiesner, Louvina E van der Laan, Barend Fourie, James Nielsen, H Simon Schaaf, Radojka M Savic, Anthony J Garcia-Prats
Moxifloxacin pharmacokinetics, cardiac safety, and dosing for the treatment of rifampicin-resistant tuberculosis in children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Kendra K Radtke, Jennifer E Hibma, Anneke C Hesseling, Rada M Savic
Pragmatic global dosing recommendations for the 3-month, once-weekly rifapentine and isoniazid preventive TB regimen in children. The European respiratory journal 57 (1) (2021)
Kendra K Radtke, Jacqueline P Ernest, Nan Zhang, Nicole C Ammerman, Eric L Nuermberger, Robert Belknap, Rosanna Boyd, Timothy R Sterling, Radojka M Savic
Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study. Antimicrobial agents and chemotherapy 65 (12) (2021)